Delivery Order SPE2DB20D1047-SPE2DB25FF58K

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,501.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,084,911 units of dextroamphetamine-amphetamine 20 mg capsules. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA, valued at $999,999,999.00. This IDC provides a comprehensive global pharmaceutical support vehicle for the...
This federal contract award, valued at $1,421.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,116,082 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract has an ultimate completion date of May 5, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,651.94 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the provision of 4,560,327,672 tablets of dextroamphetamine-amphetamine 5 mg, a medication commonly used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The delivery order has a firm fixed price and an ultimate completion...
This federal contract award is for the delivery of 10 mg tablets of the medication dextroamphetamine-amphetamine, with a ceiling value of $4,099.20. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This contract award is for the delivery of 4,566,502,384 tablets of dextroamphetamine-amphetamine 15 mg, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The $1,658.24 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024. The contract has an ultimate completion date of November 21, 2024 and was not set aside for any specific...
This federal contract award, valued at $2,103.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,982,989 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, designated as SPE2DX, with a total...
This federal contract award, valued at $31,743.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,555,721,400 units of the prescription drug dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of December 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,479.10, is for the delivery of 4,568,033,530 units of the prescription medication dextroamphetamine-amphetamine 20 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,038.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 20 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,004.80 contract is for the supply of 4,567,927,137 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg Capsules. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF58K
    Delivery Order

This federal contract award, valued at $1,300.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,142,281 capsules of dextroamphetamine-amphetamine 20 mg, a medication used to treat conditions such as ADHD.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA, valued at $999,999,999.00. This IDC serves as a comprehensive global pharmaceutical support vehicle for the DLA, U.S. Coast Guard, and other government agencies, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies. The current delivery order does not have a set-aside designation, indicating open competition. The contract has a firm fixed-price pricing type and a performance period extending until May 6, 2025.

Generated 8/10/25, 12:54 AM